1.The Treatment of de Qurvain's Disease
Duck Yun CHO ; Young Gil HAHM ; Chang Wan SEON
The Journal of the Korean Orthopaedic Association 1996;31(5):1099-1104
We treated the 90 wrists (83 patients) with de Quervain's disease, and studied retrospectively the factors affecting the result of treatment, and the results of several treatment modalities, compared with published series of this disease. There was significant association between outcome and duration of symptoms before treatment, but age, sex, associated disease, and hand dominance were not associated(chi-square test, p < 0.05). And 75 wrists received single injections of steroid and local anesthetic into the tendon sheaths with complete pain relief in 59 wrists (69%). Furthermore, an additional injection gave pain abatement in 6 wrists. And regardless of treatment method, 95% of the whole patients had satisfactory outcome at a mean of 54 months (minimum follow-up, 45 months). We concluded that injection of steroid is the preferred initial treatment in de Quervain's disease, giving complete and lasting relief in 87% of cases.
De Quervain Disease
;
Follow-Up Studies
;
Hand
;
Humans
;
Methods
;
Retrospective Studies
;
Tendons
;
Wrist
2.Combination Chemotherapy with VP - 16 , Ifosfamide , and Cisplatin ( VIP ) in the Advanced Non - Small Cell Lung Cancer.
Yong Seon CHO ; Si Young KIM ; Jeong Hee KIM ; Hwi Joong YOON ; Kyung Sam CHO
Journal of the Korean Cancer Association 2000;32(1):86-92
PURPOSE: We conducted a phase II study in previously untreated patients with unresectable stage IIIB or IV non-small cell lung cancer to evaluate the response rate and toxicity of the combination chemotherapy regimen of etoposide, ifosfamide and cisplatin. MATERIALS AND METHODS: From September 1993 to December 1996, twenty patients with advanced non-small cell lung cancer (stage IIIB 5 and IV 15) (squamous cell 8, adeno- carcinoma 12), were enrolled in this study. There were 13 (65%) males and 7 (35%) females, and median age of patients were 56 years (range: 34~66). Eighteen patients had performance status (ECOG) 0~1, two patients had performance status 2. Treatment was consisted of cisplatin (20 mg/m2 i.v., day 1~4), VP-16 (etoposide) (75 mg/m2 i.v., day 1~4), ifosfamide (1000 mg/m2 i.v., day 1~4) with mesna. This treatment was repeated every four weeks. RESULTS: The overall response rate was 25%. Complete response rate was 5% (1/20) and partial response rate was 20% (4/20). The median cycle of response was 4 (2~6) cycles. The median overall survival time was 28 weeks (9~98 weeks). The median time to progression was 10 weeks (3~50 weeks). Toxicities were evaluated by WHO criteria. Toxicity > GradeIII included: leukopenia 1.6%, thrombocytopenia 3.2%, nausea and vomiting 15%, alopecia 30%, stomatitis 10%. These toxicities were tolerable and reversible. CONCLUSION: VIP regimen was not superior to previous regimens for advanced non-small all lung cancer, and the toxicities were tolerable.
Alopecia
;
Carcinoma, Non-Small-Cell Lung
;
Cisplatin*
;
Drug Therapy, Combination*
;
Etoposide
;
Female
;
Humans
;
Ifosfamide*
;
Leukopenia
;
Lung Neoplasms
;
Male
;
Mesna
;
Nausea
;
Small Cell Lung Carcinoma*
;
Stomatitis
;
Thrombocytopenia
;
Vomiting
3.A Case of Epstein's Syndrome.
Seon Young CHOI ; Hyun Chul CHAE ; Hae Young CHO ; Hong Bae KIM ; Ji Sub OH
Journal of the Korean Pediatric Society 1994;37(11):1610-1614
Epstein's syndrome is a rare disease whish is characterized by the association of thrombocytopenia, macrothrombocytopathia, nephritis and deafness. We experienced a case of Epstein's syndrome in a 12 years old male patient who was presented with a life long history of bleeding, usually as epistaxis, bilateral sensorineural deafness and hematuria with proteinuria starting in late childhood. Hematologic studies showed thrombocytopenia with giant platelets and anemia. A bone marrow aspirate revealed the megakaryocytes to be adequate in number and many giant size platelets. Platelet do not respond to addition of A and epinephrine; collagen and ristocetin induced agglutination response is decreased. It is difficult to be certain the association of thrombocytopenia with giant platelets, nephritis and deafness constitutes a new hereditary disease with a distinct pathogenesis or if it is an expansion of the well recognized Alport's syndrome of hereditary nephritis deafness. We report a case of Epstein's syndrome syndrome with brief review of related literatures.
Agglutination
;
Anemia
;
Blood Platelets
;
Bone Marrow
;
Child
;
Collagen
;
Deafness
;
Epinephrine
;
Epistaxis
;
Genetic Diseases, Inborn
;
Hematuria
;
Hemorrhage
;
Humans
;
Male
;
Megakaryocytes
;
Nephritis
;
Nephritis, Hereditary
;
Proteinuria
;
Rare Diseases
;
Ristocetin
;
Thrombocytopenia
4.Total pelvic exenteration.
Kwang Soo YOON ; Min Young KIM ; Nam Cheon CHO ; Dae Sung KIM ; Byoung Seon RHEE
Journal of the Korean Society of Coloproctology 1992;8(3):227-234
No abstract available.
Pelvic Exenteration*
5.IgG4-Related Sclerosing Sialadenitis: Report of Three Cases.
Ji Seon BAE ; Joo Young KIM ; Sang Hak HAN ; Seung Ho CHOI ; Kyung Ja CHO
Korean Journal of Pathology 2011;45(Suppl 1):S36-S40
Chronic sclerosing sialadenitis, Mikulicz disease or Kuttner tumor has been recently recognized as a spectrum of IgG4-related sclerosing disease. IgG4-related disease is characterized by a high serum IgG4 level and tissue infiltration of IgG4-positive plasmacytes. We report three cases of chronic sclerosing sialadenitis with variably associated systemic involvement. All patients presented with a submandibular mass or swelling, and all the resected submandibular glands showed diffuse lymphocytic infiltration, lymphoid follicles, and septal fibrosis. Two of the specimens revealed numerous IgG-positive plasma cells, most of which were IgG4-positive on immunohistochemical staining. One of them was associated with dacryoadenitis and hypophysitis. The other patient had ureterorenal lesions. Immunohistochemical study was unavailable in remaining one case, but the histologic features along with elevated IgG level and associated pancreatitis supported the diagnosis. All patients received steroid therapy postoperatively and are doing well. Salivary gland involvement in IgG4-related fibrosclerosis should be recognized in systemic medical pathology.
Dacryocystitis
;
Fibrosis
;
Humans
;
Immunoglobulin G
;
Mikulicz' Disease
;
Pancreatitis
;
Plasma Cells
;
Salivary Glands
;
Sialadenitis
;
Submandibular Gland
6.CT and MR Findings of Cavernous Sinus Lesionst.
Mee Young CHO ; Seon Hee PARK ; Sang Hum YOON ; Jong Deok KIM
Journal of the Korean Radiological Society 1994;30(1):19-26
PURPOSE: To classify the cavernous sinus lesions, to describe their radiological findings, and to assess the usefulness of MR compared to CT. METHODS AND MATERIALS: Fourty-five patients with lesions involving the cavernous sinus proved by histological and/or clinical and imaging methods were studied retrospectively and classified into neoplastic, vascular, and inflammatory lesions. CT and MR findings were compared in 21 patients evaluated by both modalities simultaneously according to these 4 categories. RESULTS: Pitiutary macroadenoma was the most common cavernous sinus lesion(42%). Diffuse convex bulging of the lateral wall of cavernous sinus was the most frequent radiological finding(84%), and the others were encasement of the cavernous carotid artery(49%), remodelling of the surrounding bones(44%), and complete obliteration of Meckel's cave(38%), in descending order of frequency. Bulging of the lateral wall of cavernous sinus was equally well demonstrated on both modalities, but encasement or displacement of the cavernous carotid artery and complete or partial obliteration of Meckel's cave were much better delineated on MR than on CT with the ratio of 3.8:1 and 4.6: 1, respectively. Only bone changes were much better demonstrated on CTthan on MR with the ratio of 3.8: 1. CONCLUSION: MR issuperior to CTin demonstrating thecavernouscarotid artery encasement and obliteration of Meckel's cave, but CT is much better than MR in demonstrating bone changes.
Arteries
;
Carotid Arteries
;
Cavernous Sinus*
;
Humans
;
Retrospective Studies
7.A Case of Cloacal Extrophy.
Byung Ho LEE ; Soon Seon LIM ; Young Ha KIM ; Moon Ki CHO
Journal of the Korean Pediatric Society 1988;31(3):404-409
No abstract available.
8.Clinical Observation of Dds Induced Methemoglobinemia.
Hee Seon AUH ; Kwan Hwooy CHO ; Kir Young KIM ; Duk Jin YUN ; Sook Pyo KWON
Journal of the Korean Pediatric Society 1983;26(3):257-264
No abstract available.
Methemoglobinemia*
9.Cardiovascular Risk Factors Predicting Endothelial Dysfunction in Patients with Variant Angina.
Sook Hee CHO ; Seon Young HWANG ; Myung Ho JEONG
Journal of Korean Academy of Adult Nursing 2009;21(5):477-488
PURPOSE: This study was conducted to identify the clinical characteristics and risk factors on the occurrence of variant angina, and to examine the predicting factors on the vascular endothelial dysfunction of the patients with variant angina. METHODS: A total of 134 patients diagnosed with variant angina were recruited from 2006 to 2008. The degrees of endothelial dysfunction were measured and recorded by the researcher using the values of flow-mediated vasodilation of their brachial arteries and Nitroglycerine-mediated dilation. Subjects' demographic data and risk factors were gathered after obtaining informed consent, and their electronic medical records were reviewed to collect laboratory data. RESULTS: The mean age was 54.2 +/- 9.6 years and 52% was male patients. More than 50% of the male patients were cigarette smokers and had hypercholesterolemia. 84% of the male patients and 70% of the female patients had more than one risk factor of cardiovascular disease. A stepwise multiple regression analysis showed that smoking and hypercholesterolemia predicted the decrease of flow-mediated vasodilation (Adjusted R(2) = .204, p < .001). CONCLUSION: Tailored educational interventions for smoking cessation and cholesterol management are needed to prevent recurrence of angina attack for patients with variant angina and to prevent cardiovascular disease for middle-aged workers.
Angina Pectoris, Variant
;
Brachial Artery
;
Cardiovascular Diseases
;
Cholesterol
;
Electronic Health Records
;
Female
;
Humans
;
Hypercholesterolemia
;
Informed Consent
;
Male
;
Recurrence
;
Risk Factors
;
Smoke
;
Smoking
;
Smoking Cessation
;
Tobacco Products
;
Vasodilation
10.Cardiovascular Effects of Pancuronium, Vecuronium and Pipecuronium during High-Dose Fentanyl Anesthesia in Neonates, Infants and Children.
Young Jhoon CHIN ; Gi Baeg HWANG ; Sang Bum KIM ; Sang Seon CHO
Korean Journal of Anesthesiology 1997;33(4):669-675
BACKGROUND: High dose fentanyl for cardiac surgery in neonates, infants and children can cause severe bradycardia and chest wall rigidity that result in decreased cardiac output and oxygen desaturation due to fixed stroke volume in pediatric patients. To ameliorate the effects of fentanyl, it is common to administer neuromuscular blocking drugs with wanted cardiovascular side effects. This study was designed to compare the cardiovascular variables and oxygen saturation among different muscular relaxants in high dose fentanyl anesthesia. METHODS: Thirty pediatric cardiac patients were allocated randomly into three muscle relaxant groups treated with 0.2 mg/kg pancuronium (n=10), 0.2 mg/kg vecuronium (n=10) or 0.2 mg/kg pipecuronium (n=10) after receiving an initial bolus dose of 25 g/kg of fentanyl. Changes of heart rate (HR), mean arterial blood pressure (MAP), rate-pressure-product (RPP) and oxygen saturation (SpO2) were observed. The same cardiovascular variables were also observed 1 and 2 minutes after the second bolus dose of 25 g/kg fentanyl and compared to the results among muscle relaxants. RESULTS: HR, MAP and RPP decreased significantly (p<0.05) 1 and 2 minutes after injection of the 1st fentanyl, which returned to levels above the control value after administration of pancuronium, vecuronium or pipecuronium. Among muscle relaxants, pancuronium caused the most rapid and significantly high level compared to the control value in HR and MAP. Next was pipecuronium and then vecuronium. In clinical setting, SpO2 was decreased after the 1st fentanyl injection and increased after the injection of muscle relaxants, but not significant statistically. CONCLUSION: In view of hemodynamic changes, pancuronium is most efficient and rapid in returning the hemodynamic variables that was decreased after high dose fentanyl anesthesia in neonates, infants and children whose cardiac output was dependent on HR due to relatively fixed stroke volume.
Anesthesia*
;
Arterial Pressure
;
Bradycardia
;
Cardiac Output
;
Child*
;
Fentanyl*
;
Heart Rate
;
Hemodynamics
;
Humans
;
Infant*
;
Infant, Newborn*
;
Neuromuscular Blockade
;
Oxygen
;
Pancuronium*
;
Pipecuronium*
;
Stroke Volume
;
Thoracic Surgery
;
Thoracic Wall
;
Vecuronium Bromide*